These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 15823830)
1. The effect of relcovaptan (SR 49059), an orally active vasopressin V1a receptor antagonist, on uterine contractions in preterm labor. Steinwall M; Bossmar T; Brouard R; Laudanski T; Olofsson P; Urban R; Wolff K; Le-Fur G; Akerlund M Gynecol Endocrinol; 2005 Feb; 20(2):104-9. PubMed ID: 15823830 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of SR 49059 on oxytocin-and vasopressin-induced uterine contractions in non-pregnant women. Steinwall M; Bossmar T; Gaud C; Akerlund M Acta Obstet Gynecol Scand; 2004 Jan; 83(1):12-8. PubMed ID: 14678081 [TBL] [Abstract][Full Text] [Related]
3. [Tocolysis with the beta-adrenomimetic Partusisten in premature labor]. Ivanov S Akush Ginekol (Sofiia); 1997; 36(2):9-10. PubMed ID: 9471910 [TBL] [Abstract][Full Text] [Related]
4. Effects of SR 49059, an orally active V1a vasopressin receptor antagonist, on vasopressin-induced uterine contractions. Bossmar T; Brouard R; Döberl A; Akerlund M Br J Obstet Gynaecol; 1997 Apr; 104(4):471-7. PubMed ID: 9141585 [TBL] [Abstract][Full Text] [Related]
5. Tocolytic effects of intravenous nitroglycerin. de Spirlet M; Treluyer JM; Chevret S; Rey E; Tournaire M; Cabrol D; Pons G Fundam Clin Pharmacol; 2004 Apr; 18(2):207-13. PubMed ID: 15066136 [TBL] [Abstract][Full Text] [Related]
6. SSR126768A (4-chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, hydrochloride): a new selective and orally active oxytocin receptor antagonist for the prevention of preterm labor. Serradeil-Le Gal C; Valette G; Foulon L; Germain G; Advenier C; Naline E; Bardou M; Martinolle JP; Pouzet B; Raufaste D; Garcia C; Double-Cazanave E; Pauly M; Pascal M; Barbier A; Scatton B; Maffrand JP; Le Fur G J Pharmacol Exp Ther; 2004 Apr; 309(1):414-24. PubMed ID: 14722330 [TBL] [Abstract][Full Text] [Related]
7. Relationship between uterine contractions and serum magnesium levels in patients treated for threatened preterm labour with intravenous magnesium sulphate. Lurie S; Gur D; Sadan O; Glezerman M J Obstet Gynaecol; 2004 Apr; 24(3):247-8. PubMed ID: 15203617 [TBL] [Abstract][Full Text] [Related]
8. [Tocolytic treatment of pregnant women with threatened abortions and preterm labor in the second and third trimesters of pregnancy with magne B6 (a preliminary communication)]. Marinov B; Damianov L; Tsache K; Atanasova B Akush Ginekol (Sofiia); 1999; 38(1):74-6. PubMed ID: 11965731 [TBL] [Abstract][Full Text] [Related]
9. A potential novel strategy, inhibition of vasopressin-induced VEGF secretion by relcovaptan, for decreasing the incidence of ovarian hyperstimulation syndrome in the hyperstimulated rat model. Cenksoy C; Cenksoy PO; Erdem O; Sancak B; Gursoy R Eur J Obstet Gynecol Reprod Biol; 2014 Mar; 174():86-90. PubMed ID: 24405730 [TBL] [Abstract][Full Text] [Related]
10. Uterine contraction frequency before and after successful tocolytic therapy for preterm uterine contractions. Newman RB; Johnson F; Das A; Goldenberg RL; Swain M; Moawad A; Sibai BM; Caritis SN; Miodovnik M; Paul RH; Dombrowski MP; Collins Sharp BA; Fischer M J Reprod Med; 2003 Nov; 48(11):843-9. PubMed ID: 14686015 [TBL] [Abstract][Full Text] [Related]
11. Uterine activity after oral mifepristone administration in human pregnancies beyond 41 weeks' gestation. Fassett MJ; Wing DA Gynecol Obstet Invest; 2008; 65(2):112-5. PubMed ID: 17912003 [TBL] [Abstract][Full Text] [Related]
12. Relationship of measured external tocodynamometry with measured internal uterine activity. Paul MJ; Smeltzer JS Am J Perinatol; 1991 Nov; 8(6):417-20. PubMed ID: 1814307 [TBL] [Abstract][Full Text] [Related]
13. Oxytocin receptor blockade: a new principle in the treatment of preterm labor? Andersen LF; Lyndrup J; Akerlund M; Melin P Am J Perinatol; 1989 Apr; 6(2):196-9. PubMed ID: 2540760 [TBL] [Abstract][Full Text] [Related]
14. Tocolytic effect of a selective FP receptor antagonist in rodent models reveals an innovative approach to the treatment of preterm labor. Chollet A; Tos EG; Cirillo R BMC Pregnancy Childbirth; 2007 Jun; 7 Suppl 1(Suppl 1):S16. PubMed ID: 17570160 [TBL] [Abstract][Full Text] [Related]